ReviewPharmacoEconomics - open2019

A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers.

Naghmeh Foroutan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.